421 related articles for article (PubMed ID: 29047238)
1. Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.
Lee CY; Hong JY; Lee MG; Suh IB
Yonsei Med J; 2017 Nov; 58(6):1144-1151. PubMed ID: 29047238
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of different pleural fluid biomarkers in tuberculous pleurisy.
Klimiuk J; Krenke R; Safianowska A; Korczynski P; Chazan R
Adv Exp Med Biol; 2015; 852():21-30. PubMed ID: 25523627
[TBL] [Abstract][Full Text] [Related]
4. Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions.
Yang WB; Liang QL; Ye ZJ; Niu CM; Ma WL; Xiong XZ; Du RH; Zhou Q; Zhang JC; Shi HZ
PLoS One; 2012; 7(7):e40450. PubMed ID: 22792330
[TBL] [Abstract][Full Text] [Related]
5. Differentiating tuberculous from malignant pleural effusions: a scoring model.
Porcel JM; Vives M
Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
[TBL] [Abstract][Full Text] [Related]
6. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
Wang M; Zhang Z; Wang X
Clinics (Sao Paulo); 2014; 69(12):799-803. PubMed ID: 25627990
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of interferon-gamma in tuberculous pleural effusions.
Aoe K; Hiraki A; Murakami T; Eda R; Maeda T; Sugi K; Takeyama H
Chest; 2003 Mar; 123(3):740-4. PubMed ID: 12628872
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
Ni SS; Gao ZL
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
[TBL] [Abstract][Full Text] [Related]
9. [Significance of detecting E-selectin of serum and pleural effusion in differentiating benign and malignant diseases].
Liu G; Li C; Zhong X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):556-8. PubMed ID: 11360510
[TBL] [Abstract][Full Text] [Related]
10. [Adenosine deaminase activity in tuberculous and malignant pleural effusions].
Safianowska A; Krenke R; Dmowska-Sobstyl B; Bogacka-Zatorska E; Domagała-Kulawik J; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):5-9. PubMed ID: 17175968
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions.
Al-Aarag AH; Kamel MH; Abdelgawad ER; Abo-Youssef SM; Moussa HH; Elnaggar ME; Hendy RM; Diab KA
BMC Pulm Med; 2019 Jun; 19(1):114. PubMed ID: 31238901
[TBL] [Abstract][Full Text] [Related]
12. [Pleural fluid interferon-gamma (IFN-gamma) measurement as a diagnostic tool in tuberculous pleurisy].
Krenke R; Safianowska A; Paplińska M; Korczyński P; Dmowska-Sobstyl B; Bogacka-Zatorska E; Jaworski A; Chazan R
Pneumonol Alergol Pol; 2008; 76(4):237-45. PubMed ID: 18785128
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.
Hua CC; Chang LC; Chen YC; Chang SC
Chest; 1999 Nov; 116(5):1292-6. PubMed ID: 10559090
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion.
Orphanidou D; Gaga M; Rasidakis A; Dimakou K; Toumbis M; Latsi P; Pandalos J; Christacopoulou J; Jordanoglou J
Respir Med; 1996 Feb; 90(2):95-8. PubMed ID: 8730328
[TBL] [Abstract][Full Text] [Related]
15. Development of a time-resolved fluoroimmunoassay of CFP-10 for rapid diagnosis of tuberculous pleural effusion.
Lu J; Zou L; Liu B; Li X; Tan J; Zhao A; Xiong C; Li X; Lu J; Gao J
Tuberculosis (Edinb); 2015 Jul; 95(4):426-31. PubMed ID: 26055814
[TBL] [Abstract][Full Text] [Related]
16. Crucial role of CD4+CD 25+ FOXP3+ T regulatory cell, interferon-γ and interleukin-16 in malignant and tuberculous pleural effusions.
Ibrahim L; Salah M; Abd El Rahman A; Zeidan A; Ragb M
Immunol Invest; 2013; 42(2):122-36. PubMed ID: 23252864
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.
Momi H; Matsuyama W; Inoue K; Kawabata M; Arimura K; Fukunaga H; Osame M
Respir Med; 2002 Oct; 96(10):817-22. PubMed ID: 12412982
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic flowchart for tuberculous pleurisy, pleural infection, and malignant pleural effusion.
Shimoda M; Tanaka Y; Morimoto K; Yoshiyama T; Yoshimori K; Ohta K
Respir Investig; 2024 Jan; 62(1):157-163. PubMed ID: 38141528
[TBL] [Abstract][Full Text] [Related]
19. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
20. [Early secretory antigenic target protein-6/culture filtrate protein-10 fusion protein-specific Th1 and Th2 response and its diagnostic value in tuberculous pleural effusion].
Ge QP; He ZY; Gao WW; DU FJ; Wei PJ; Jia HY; Ma Y; Zhang ZD
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):406-10. PubMed ID: 24103202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
